Joe Y Chang

7PUBLICATIONS
37CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 18, 2026
CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer.

|Oct 06, 2025
Causal AI-based clinical and radiomic analysis for optimizing patient selection in combined immunotherapy and SABR in early-stage NSCLC: a secondary analysis of the phase II I-SABR trial.

Maliazurina B Saad, Eman Showkatian, Vivek Verma

|Oct 09, 2024
Phase I/II study of BMS-986156 with ipilimumab or nivolumab with or without stereotactic ablative radiotherapy in patients with advanced solid malignancies.

Joe Y Chang, Xinyan Xu, Girish S Shroff

|Sep 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.

Joanne B Weidhaas, Chen Hu, Ritsuko Komaki

|Mar 30, 2023
Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review and meta-analysis.

Yajing Wu, Vivek Verma, Carl M Gay

|Feb 13, 2021
Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.

Anas Alshawa, Alexandra Perez Cadena, Bettzy Stephen

Pageof 2

Frequent Collaborators

2 joint publications

Jia Wu

2 joint publications

Jianjun Zhang

2 joint publications

Natalie I Vokes

1 joint publications

Ajay Sheshadri